I said trust was the hard part. This week, one of the industry's toughest voices seemed to agree.
A little while ago, I wrote here about a conviction I have carried since I left medicine to build Doceree: that the future of how medicine gets communicated would be won in the conversation — and that the hard part, the part most of the noise around AI in healthcare skips over, is making that conversation trustworthy. Governed. Compliant. Safe enough to put in front of a physician at the moment a clinical decision is made.
This week, that conviction got a kind of validation I did not expect to feel as deeply as I did.
Doceree has been listed as a Sample Vendor in the Trusted Conversational AI in Life Sciences profile of the 2026 Gartner® Hype Cycle™ for Life Science Enterprise Technologies — alongside companies like OpenAI, Anthropic and Veeva Systems.
I have read that sentence a few times now, and it still lands.
Why this one matters to me
I have been fortunate to receive recognition over the years, and I am wary of how easily a founder can start chasing it. So let me be honest about why this particular line in a research report moved me.
It is not a press release we wrote. It is not a placement we paid for. The Hype Cycle is the report that life science CIOs actually use to decide where their industry is heading and where to place their bets. An independent analyst looked across the entire landscape of how medicine will be communicated in this decade — and decided our name belonged next to the companies defining the era.
Gartner classifies this category as one it rates High in benefit, and still early in its maturity. That second part is the part I keep coming back to. Being named while a category is still being shaped is not a participation badge. It is evidence that we saw where this was going before the market caught up — and that we spent five years building toward it while it was still unfashionable to do so.
The bet we made
Five years ago, the question that pulled me out of clinical practice was a simple one: why does a physician prescribe what they prescribe? I became convinced the answer did not live in louder marketing or more impressions. It lived in the conversation — at the point of care, in the workflow, in the exact moment a decision is made — and that whoever could make that conversation trusted, governed, and compliant at scale would help shape how medicine is practiced.
That belief sent us toward a lot of work that does not show up in a demo. The identity infrastructure. The integrations into the places clinicians work. The unglamorous, exacting discipline of making sure every response is bounded by approved content, traceable, and defensible — because in medicine, a wrong answer is not a bad user experience; it is a clinical risk.
To see that work recognized as representative of where the entire category is heading is, frankly, the kind of moment you build a company hoping for and rarely let yourself expect.
This belongs to the team
I want to be very clear about something. Our name is in that report not because of me, but because of the people I get to build alongside every day. Every engineer, every clinician on our team, every person who chose the hard, correct path over the fast one — this is theirs. I am proud of them in a way that is difficult to put into words.
What comes next
Recognition is a milestone, not a finish line. The truth is that the category Gartner is describing is still in its earliest chapters, and the responsibility that comes with being named this early is to keep earning it. We have a lot to prove, and a lot we intend to ship — including some of the most important work of our company's life in the months ahead.
The question I started with has not changed. Why does a physician prescribe what they prescribe? I am more convinced than ever that the answer lives in the conversation — and I am grateful, this week, that some of the people who watch this industry most closely seem to think so too.
Onward.
— Harshit Jain, MD Founder & Global CEO, Doceree